- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02383732
A Study of the Elopement Prevention and Safety Training Program
March 28, 2017 updated by: Nathan A. Call, Ph.D., BCBA-D, Emory University
A Feasibility Study of the Elopement Prevention and Safety Training Program
The purpose of this study is to demonstrate the feasibility of the Elopement Prevention Safety (EPST) program in children with autism spectrum disorder (ASD) who have engaged in eloping.
This is a program created by the Behavior Treatment Clinics to help caregivers come up with a safety plan to prevent their children from running away or wandering off.
Study Overview
Status
Completed
Conditions
Detailed Description
A large number of children with autism spectrum disorder (ASD) have a current or past history of elopement.
For parents of a child with ASD, having their child go missing is potentially dangerous and far more likely compared to typically developing children.
This behavior interferes with household routines, engenders vigilance, and restricts the family's participation in their community.
Such restrictions contribute to the family's isolation and hinders development of community supports.
Elopement can result in injuries and deaths of children with ASD.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30329
- Marcus Autism Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and females, ages 4 to 12 inclusive
- Diagnosis of ASD as determined by clinical interview and supported by standardized measures (i.e., Autism Diagnostic Observation Schedule-2, Vineland, Stanford-Binet V)
- Engages in elopement in the form of bolting or wandering, as determined by structured interview
- A caregiver who expresses a willingness to participate in treatment and complete baseline/outcome assessments.
Exclusion Criteria:
- Unmanaged psychopathology or problem behavior other than elopement that warrants immediate clinical care, determined by clinical interview and Aberrant Behavior Checklist (ABC)
- Child and family currently in therapy that is likely to be redundant with the treatment program or interfere with proposed treatment
- Presence of both of the types of elopement under investigation (i.e., both bolting and wandering).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment
Pediatric subjects between the age of 4-12 years with autistic spectrum disorder and elopement will begin the Elopement Prevention and Safety Training (EPST) program.
EPST includes up to 12 120-minute weekly sessions delivered over approximately 12-14 weeks.
EPST is a modular treatment, with three components: 1) Universal Safety Measures (USM), 2) Proximity training, and 3) Check-in training.
All participants receive the USM module in the first two sessions.
They then receive either the Proximity training or Check-in training module depending on the type of elopement exhibited by the child (i.e., bolting vs. wandering).
|
During the first session, the therapist conducts a home safety evaluation.
During the second visit the therapist provides the caregiver with an individualized Elopement Prevention & Safety Plan (EPSP) based upon the results of the evaluation.
The remainder of the session is spent helping caregivers make plans to implement the EPSP to reduce the risk of elopement or lessen the risk of harm to the child if they do successfully elope.
During the first session a functional behavioral assessment (FBA) of bolting is conducted to identify the motivator(s) that evoke bolting.
Caregivers identify a setting that is most problematic because it contains the item/activity that most frequently serves as a motivator for elopement.
In the next session, caregivers are taught to identify effective alternative reinforcers.
In subsequent sessions, antecedent and consequence based strategies are employed to reduce motivation for elopement and reinforce remaining within the designated proximity of a caregiver for increasing durations.
This module employs behavioral strategies to teach a child to check in with a caregiver at frequent fixed intervals during periods of low supervision.
Delivering potent reinforcement for checking in counteracts any motivation to wander.
Furthermore, if the child does wander caregivers become aware of it immediately because they failed to check in.
During the first session caregivers are taught to identify effective reinforcers.
A vibrating alarm that can be carried in a participating child's pocket serves as a prompt to seek out a caregiver and check-in.
Participants receive access to a previously identified and individualized reinforcer for checking-in with the caregiver.
|
|
Active Comparator: Waitlist Control
Pediatric subjects between the age of 4-12 years with autistic spectrum disorder and elopement will be assigned to the Waitlist Control group.
The subjects will be offered the intervention after completion of the 12-week waiting period.
The subjects will then begin the Elopement Prevention and Safety Training (EPST) program.
EPST includes up to 12 120-minute weekly sessions delivered over approximately 12-14 weeks.
EPST is a modular treatment, with three components: 1) Universal Safety Measures (USM), 2) Proximity training, and 3) Check-in training.
All participants receive the USM module in the first two sessions.
They then receive either the Proximity training or Check-in training module depending on the type of elopement exhibited by the child (i.e., bolting vs. wandering).
|
During the first session, the therapist conducts a home safety evaluation.
During the second visit the therapist provides the caregiver with an individualized Elopement Prevention & Safety Plan (EPSP) based upon the results of the evaluation.
The remainder of the session is spent helping caregivers make plans to implement the EPSP to reduce the risk of elopement or lessen the risk of harm to the child if they do successfully elope.
During the first session a functional behavioral assessment (FBA) of bolting is conducted to identify the motivator(s) that evoke bolting.
Caregivers identify a setting that is most problematic because it contains the item/activity that most frequently serves as a motivator for elopement.
In the next session, caregivers are taught to identify effective alternative reinforcers.
In subsequent sessions, antecedent and consequence based strategies are employed to reduce motivation for elopement and reinforce remaining within the designated proximity of a caregiver for increasing durations.
This module employs behavioral strategies to teach a child to check in with a caregiver at frequent fixed intervals during periods of low supervision.
Delivering potent reinforcement for checking in counteracts any motivation to wander.
Furthermore, if the child does wander caregivers become aware of it immediately because they failed to check in.
During the first session caregivers are taught to identify effective reinforcers.
A vibrating alarm that can be carried in a participating child's pocket serves as a prompt to seek out a caregiver and check-in.
Participants receive access to a previously identified and individualized reinforcer for checking-in with the caregiver.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of intervention, assessed by change in severity on Clinical Global Impression for Severity (CGI-S)
Time Frame: Post-intervention (12-14 weeks)
|
An independent evaluator (IE) will conduct a parent target problem survey to help caregivers estimate the frequency of elopement as well as its impact on the family.
From this description, the IE (who will be blind to treatment assignment) will generate a brief narrative describing the participant's elopement.
This narrative will be used by the IE to rate the overall severity on the 7-point Clinical Global Impression for Severity (CGI-S).
Clinical Global Impression of Severity (CGI-S) Scale is a clinician's assessment of patient's severity of illness.
The score ranges from 1 = normal, not at all ill to 7 = among the most extremely ill patients
|
Post-intervention (12-14 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in elopement behavior
Time Frame: Post-intervention (12-14 weeks)
|
Number of times a subject exhibits bolting and wandering at baseline and post-intervention.
Change in elopement will be subtracting the number of bolting and wandering events from post-intervention and baseline.
|
Post-intervention (12-14 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nathan Call, PhD, Emory University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2015
Primary Completion (Actual)
January 31, 2017
Study Completion (Actual)
January 31, 2017
Study Registration Dates
First Submitted
February 25, 2015
First Submitted That Met QC Criteria
March 3, 2015
First Posted (Estimate)
March 9, 2015
Study Record Updates
Last Update Posted (Actual)
March 30, 2017
Last Update Submitted That Met QC Criteria
March 28, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00076337
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityCalifornia Department of Developmental ServicesActive, not recruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
Clinical Trials on Universal Safety Measures Module (All participants)
-
Grey Wolf TherapeuticsRecruitingAxial Spondyloarthritis (AxSpA)Belgium, Poland, Netherlands, Australia, Germany, Spain
-
Women and Infants Hospital of Rhode IslandCompletedPremature Infant | Language Development | Neurodevelopmental OutcomesUnited States
-
HTL-Strefa S.A.Completed
-
AstraZenecaCompletedCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates